One of the ARIA strengths has been to communicate its vision powerfully and convincingly worldwide. Over 1,000 papers have been posted on Pubmed from over 50 countries using the ARIA recommendations 13. The number of training sessions in over 70 countries cannot be counted. ARIA was endorsed by many governments and international organizations and ARIA recommendations have been used for the labeling of allergen immunotherapy. 2-2-5- Empower others to act on the vision Organizational processes and structures are in place and are aligned with the overall organizational vision. However, we need to continuously check for barriers and for people who are resisting change. We have always been implementing proactive actions to remove the obstacles involved in the process of change. ARIA has been recognized as the major rhinitis and asthma multimorbidity guideline for years in most countries except for the US and Japan. However, the recent US guidelines are using the based approach of ARIA (GRADE: Grading of Recommendations, Assessment, Development and Evaluation) and recommendations are similar 46-48 to those of ARIA 6. The recent Japanese guidelines for AR are also making bridges with ARIA 49. 2-2-6- Generate short-term wins As proposed by Kotter 11, creating short-term wins early in the change process can give a feel of victory in the early stages of change instead of one long-term goal. The concept of asthma and rhinitis multimorbidity is now globally accepted without any doubt in developed and developing countries 50. It is now recognized that multimorbidity is independent of IgE-mediated allergy 51,52 and new phenotypes of severe airway diseases have been identified. The implementation of the multimorbid concept in clinical practice has a direct benefit for the patient for whom nasal symptoms are often more bothersome than asthma. 2-2-7- Consolidate gains and produce more change 11 The goals of step 7 are to achieve continuous improvement by analysing the success stories individually and improving from those individual experiences. These goals are exactly those followed by ARIA for the past 18 years.. 2-2-8- Anchor new approaches in the culture and institutionalize the changes The goals of step 8 11 are met by the ARIA strategy: Discuss the successful stories related to change initiatives widely. Ensure that the change becomes an integral part of the practice and is highly visible. Ensure that the support of the existing as well as the new leaders continues to extend towards the change. 2-3- Drawbacks and solutions
One of the ARIA strengths has been to communicate its vision powerfully and convincingly worldwide. Over 1,000 papers have been posted on Pubmed from over 50 countries using the ARIA recommendations 13. The number of training sessions in over 70 countries cannot be counted. ARIA was endorsed by many governments and international organizations and ARIA recommendations have been used for the labeling of allergen immunotherapy. 2-2-5- Empower others to act on the vision Organizational processes and structures are in place and are aligned with the overall organizational vision. However, we need to continuously check for barriers and for people who are resisting change. We have always been implementing proactive actions to remove the obstacles involved in the process of change. ARIA has been recognized as the major rhinitis and asthma multimorbidity guideline for years in most countries except for the US and Japan. However, the recent US guidelines are using the approach of ARIA (GRADE: Grading of Recommendations, Assessment, Development and Evaluation) and recommendations are similar 46-48 to those of ARIA 6. The recent Japanese guidelines for AR are also making bridges with ARIA 49. 2-2-6- Generate short-term wins As proposed by Kotter 11, creating short-term wins early in the change process can give a feel of victory in the early stages of change instead of one long-term goal. The concept of asthma and rhinitis multimorbidity is now globally accepted without any doubt in developed and developing countries 50. It is now recognized that multimorbidity is independent of IgE-mediated allergy 51,52 and new phenotypes of severe airway diseases have been identified. The implementation of the multimorbid concept in clinical practice has a direct benefit for the patient for whom nasal symptoms are often more bothersome than asthma. 2-2-7- Consolidate gains and produce more change The goals of step 7 11 are to achieve continuous improvement by analysing the success stories individually and improving from those individual experiences. These goals are exactly those followed by ARIA for the past 18 years.. 2-2-8- Anchor new approaches in the culture and institutionalize the changes The goals of step 8 11 are met by the ARIA strategy: Discuss the successful stories related to change initiatives widely. Ensure that the change becomes an integral part of the practice and is highly visible. Ensure that the support of the existing as well as the new leaders continues to extend towards the change. 2-3- Drawbacks and solutions based
Attachment.1.a.-ARIA-change-management-30-12.docx